3.4.3 Allergic emergencies

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

65 library items in 3.4.3 Allergic emergencies

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

3: Respiratory system (remove) , 3.4 Antihistamines, hyposensitisation, and allergi (remove) , 3.4.3 Allergic emergencies (remove)

Sort by: Display summary:

Results 1 - 10 of 65

Result page:
Previous
|
1
2
3
4
5
6
7
|
Next

1.

Safe use of adrenaline autoinjectors

Source: Australian Prescriber,
Date published: 02/04/2012

Category:

3.4.3 Allergic emergencies

NeLM Area:

Evidence > Medicines Management > References

Full text link (PDF)
2.

Development and validation of educational materials for food allergy

Source: Journal of Pediatrics,
Date published: 29/03/2012

Category:

3.4.3 Allergic emergencies | Allergy | Paediatrics | Patient

NeLM Area:

Evidence > Medicines Management > References

Abstract link (ScienceDirect)
3.

SMC accepts icatibant acetate (Firazyr®) for treatment of acute attacks of hereditary angioedema

Source: Scottish Medicines Consortium (SMC),
Date published: 13/03/2012

Category:

3.4.3 Allergic emergencies | Drug reviews | Immunology and vaccination | Scottish Medicines Consortium

NeLM Area:

Evidence > Drug Specific Reviews

Drug advice
4.

Use of C1 esterase inhibitors in pregnancy

Source: UK Teratology Information Service,
Date published: 12/03/2012

Category:

3.4.3 Allergic emergencies | Drugs in pregnancy

NeLM Area:

Evidence > Drugs in Pregnancy
5.

AWMSG issues Final Appraisal Recommendation on icatibant (Firazyr®) for hereditary angioedema (HAE)

Source: All Wales Medicines Strategy Group (AWMSG),
Date published: 09/03/2012

Category:

3.4.3 Allergic emergencies | All Wales Medicines Strategy Group (AWMSG) | Immunology and vaccination

NeLM Area:

Evidence > Drug Specific Reviews

AWMSG Final Appraisal Recommendation – 0512: Icatibant (Firazyr®) February 2012
6.

FDA approves license extension of Berinert® (C1 Esterase Inhibitor) for self-administration and treatment of acute laryngeal attacks of hereditary angioedema

Source: PharmaLive,
Date published: 05/01/2012

Category:

3.4.3 Allergic emergencies | Allergy | Ear, Nose and Throat (ENT) disorders | Emergency Medicine | Food &Drug Administration (FDA) | Licence extension

NeLM Area:

News

Link
7.

Digital Epipen (R) injection: a case of conservative management

Source: Journal of Emergency Medicine,
Date published: 15/12/2011

Category:

3.4.3 Allergic emergencies | Medication errors

NeLM Area:

Evidence > Medicines Management > References

Abstract link (ScienceDirect)
8.

NICE issues costing statement on its guidance for anaphylaxis

Source: NICE,
Date published: 14/12/2011

Category:

3.4.3 Allergic emergencies | Clinical guidelines | Emergency Medicine | Health Economics | National Institute of Clinical Excellence (NICE)

NeLM Area:

News

NICE costing statement (CG134)

NICE CG134
9.

NICE issues clinical guideline on assessment and referral following emergency treatment for an anaphylactic episode

Source: NICE,
Date published: 14/12/2011

Category:

3.4.3 Allergic emergencies | Clinical guidelines | Emergency Medicine | National Institute of Clinical Excellence (NICE)

NeLM Area:

Evidence > Guidelines

NICE CG134

Link to summary in BMJ 2011; 343: d7595
10.

In brief: Icatibant (Firazyr) for hereditary angioedema

Source: Medical Letter on Drugs and Therapeutics,
Date published: 05/12/2011

Category:

3.4.3 Allergic emergencies

NeLM Area:

Evidence > Medicines Management > References

Journal website

Results 1 - 10 of 65

Result page:
Previous
|
1
2
3
4
5
6
7
|
Next